Recent studies have elucidated the central and multifaceted role that cDC1s play in orchestrating both CD8+ (79) and CD4+ (80) T cell responses, thereby determining the efficiency and durability of anti-tumor immunity. This evidence concerns the gene CD4 and neoplasm.